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Background: Tandem repeats (TRs) are unstable regions commonly found within genomes that have
consequences for evolution and disease. In humans, polymorphic TRs are known to cause neurodegenerative and
neuromuscular disorders as well as being associated with complex diseases such as diabetes and cancer. If present
in upstream regulatory regions, TRs can modify chromatin structure and affect transcription; resulting in altered
gene expression and protein abundance. The most common TRs are short tandem repeats (STRs), or microsatellites.
Promoter located STRs are considerably more polymorphic than coding region STRs. As such, they may be a
common driver of phenotypic variation. To study STRs located in regulatory regions, we have performed genome-
wide analysis to identify all STRs present in a region that is 2 kilobases upstream and 1 kilobase downstream of
the transcription start sites of genes.
Results: The Short Tandem Repeats in Regulatory Regions Table, STaRRRT, contains the results of the genome-wide
analysis, outlining the characteristics of 5,264 STRs present in the upstream regulatory region of 4,441 human genes.
Gene set enrichment analysis has revealed significant enrichment for STRs in cellular, transcriptional and neurological
system gene promoters and genes important in ion and calcium homeostasis. The set of enriched terms has broad
similarity to that seen in coding regions, suggesting that regulatory region STRs are subject to similar evolutionary
pressures as STRs in coding regions and may, like coding region STRs, have an important role in controlling gene
expression.
Conclusions: STaRRRT is a readily-searchable resource for investigating potentially polymorphic STRs that could
influence the expression of any gene of interest. The processes and genes enriched for regulatory region STRs provide
potential novel targets for diagnosing and treating disease, and support a role for these STRs in the evolution of the
human genome.
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Tandem repeats (TRs) are stretches of DNA that contain
nucleotide patterns repeated adjacent to one another and
are common throughout the human genome [1]. TRs are
classified by repeat unit length into further categories in-
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reproduction in any medium, provided the orwhich are repeats with a unit length of less than 10 nucle-
otides or base pairs (bp). TRs display a non-random distri-
bution and a particular bias in location to genic and
regulatory regions [2,3]. In humans, approximately 17% of
genes contain TRs within their coding regions [4]. In yeast
(Saccharomyces cerevisiae), approximately 25% of all gene
promoters contain at least one tandem repeat (TR), many
of these TRs consisting of short, AT-rich sequences and
the distribution of TRs in human gene promoters is
similar [5,6].
TRs have a propensity to mutate and become poly-
morphic by expansion or contraction in the number of
repeat units. This may be due to slippage during DNALtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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combination, or by imprecise repair of double-strand
DNA breaks [7-9]. TRs exhibit mutation rates around 10
to 105-fold higher than average rates for non-repeated
DNA in other parts of the genome [7,10-12]. Such poly-
morphic TRs are often described as variable number of
tandem repeats (VNTR). The frequency of TR mutations
is dependent upon the length of the repeat unit (known
as the “period”), the number of repeat units, and the
percentage match to the consensus sequence or “purity”
of the repeat tract [4,13]. The number of repeat units and
purity of the repeat tract are the most important predic-
tors for repeat variability, with an increase in the number
of repeats and/or purity resulting in a higher propensity to
be polymorphic [13,14]. Naslund et al. (2005) found that
doubling the repeat unit number corresponded to a 15-
fold increase in the likelihood of the repeat being poly-
morphic and for each 10% increase in repeat purity, an
18-fold increase in likelihood of polymorphism resulted.
STRs are a common source of genetic variation in
promoter regions and alleles can be highly variable in
length. In humans, the rate of STR length polymorphism
within 1 kb upstream of the transcription start site
(TSS) is over 12-fold higher than in exonic regions, 1.5-
fold higher than in untranslated regions (UTRs) and
almost comparable to the rate in intragenic and intronic
regions [15]. Despite this hyper-variability, there is also
evidence for promoter localised STRs being evolutio-
narily conserved [6]. The conservation rate of STRs is
dependent upon the proximity to the TSS, with closer
STRs more likely to be conserved [16].
Polymorphic TRs can affect transcription by a number
of means. Length polymorphism has consequences for
transcription, with TR-containing promoters showing
significantly higher rates of transcriptional expression
divergence [5]. In yeast, it is known that nucleosome
position is inversely correlated with tandem repeat
positions with nucleosome depletion being especially
pronounced around AT-rich repeats [5]. In addition,
altering the length of TRs in promoter regions directly
affects the local chromatin structure resulting in altered
transcriptional activity and gene expression [5,17]. Fur-
ther, potential sites of Z-DNA are enriched at the pro-
moter and 5’-end of human genes [18] and Z-DNA,
which expels bound nucleosomes, is more likely to form
where the AC/GT dinucleotide repeat is present [19].
Combined, the exceptionally high polymorphism rate,
evolutionary conservation around the TSS and evidence
for transcriptional regulation suggests that promoter
STRs are functional and may be an important source of
rapid evolutionary change. If so, STRs should also be
associated with disease.
Polymorphic TRs are implicated in more than 40
neuromuscular and neurodegenerative diseases, such asspinobulbar muscular atrophy [20] and Huntington’s
disease [21]; as well as other complex disorders such as
anxiety [22], mental retardation [23] and diabetes
[24,25]; and several cancers, such as colorectal [26,27]
and prostate cancer [28-30]. In the regulatory region, poly-
morphic STRs in the FLI1, ECE-1c and CD30 gene pro-
moters have been associated with lupus [31], Alzheimer’s
disease [32] and primary cutaneous lymphoproliferative
disorders [33], respectively.
While there is mounting evidence that STRs are an
important class of genetic variation with links to disease
phenotypes and evolution of the human genome, their
use in genetic studies has reduced with the advent of
massively parallel single nucleotide polymorphism (SNP)
analysis and genome-wide association studies (GWAS)
[34,35]. Compared with SNPs, STRs show extremely
rapid evolution, indicative of increased variability between
individual sub-populations. The observed enrichment of
STRs in genic and regulatory regions [4] also suggests
potentially larger phenotype effects than many common
SNPs. Hypervariable STRs in regulatory regions may
explain some of the missing heritability unaccounted for
by GWAS of complex disease [13,36,37]. From a human
genetics perspective, this untapped source of regulatory
STR variation could be important and also complemen-
tary to GWAS studies. Increasing interest over the past
decade in the noncoding regions of the human genome,
which has been described as “the control architecture of
the system” [38], further highlights the important role that
variation in these regions plays. Considering the influential
role of STRs in regulating gene expression, the importance
of this source of genetic variation has been over-looked.
There is currently no catalogue or easy to use resource
available for studying STRs in the regulatory regions of
human genes. This study aimed to identify, characterise
and compare STRs in the upstream regulatory region of
human genes on a genome-wide scale and establish a
resource to allow the interrogation of STRs in this
region. By screening the entire human genome, using
Tandem Repeat Finder [39], SQL code and the UCSC
Genome Browser [40], for STRs present in a 3 kilobase
region at the 5’-end of all human genes, we have identi-
fied 5,264 STRs across 4,441 genes. The information
describing the location and characteristics of these STRs
is presented in the Short Tandem Repeats in Regulatory
Regions Table, or STaRRRT (available at http://www.new
castleinnovationhealth.com.au/STaRRRT). This resource
is suitable for researchers with limited bioinformatics
experience who are interested in specific STRs, genes or
phenotypes. We have identified a unique signature of STR
enrichment in the regulatory regions of human genes
which is most pronounced within neural genes, and
calcium signaling and neurological pathways. This paper
presents the findings from investigations of the distribution
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human genes, highlighting the importance of STRs in
neurological pathways and in recent evolution of the
human genome.
Results
STaRRRT is a comprehensive, user-friendly resource with
wide application
The resource, STaRRRT, was designed to identify tan-
dem repeats in the regulatory region of genes as these
may alter transcription due to their location. Further, the
discovery of polymorphic regulatory region tandem
repeats can serve as genetic markers linked to traits.
There are many definitions of what constitutes a gene
regulatory region. Typically, eukaryotic genes contain a
core promoter, which is about 100 bp long and centered
at the transcription start site (TSS; Figure 1), and a prox-
imal promoter about 250 bp immediately upstream and
downstream of the TSS [41]. For our analyses, we define
the core and proximal promoter as having the coordi-
nates (−60 to +40 bp) and (−250 to +250 bp) respect-
ively, relative to the TSS. There is evidence to show that
some human promoters have control elements in the
region −1000 to −500 bp upstream of the TSS that can
reduce gene expression [42]. Similarly, the 5’-UTR is
known to have regulatory control elements that effect
transcription [43,44]. The STaRRRT resource covers a
3 kb region spanning −2000 to +1000, with respect to
the TSS (Figure 1). Further rationale for the selection of
this region is given in the Methods.
To increase the utility of STaRRRT, the resource is
restricted to short tandem repeats (STRs), due to their
abundance, polymorphic nature and frequent use as gen-
etic markers. In order to increase the chance of variable
STRs being predominately represented in STaRRRT, we
have restricted the purity to greater than or equal to
90%. We define an STR, also known as a microsatellite,
as those TRs with period of 1 to 9 bp. Tandem repeats
were identified from the UCSC ‘simpleRepeats’ table,
which contains output from the Tandem Repeat Finder
(TRF) program [39]. TRF uses distribution theory toFigure 1 Location of the regulatory region analysed in a representati
(marked by a red box) in a representative human gene screened in the cre
different among human genes, the 1 kb region downstream of the TSS wil
is demonstrated by the marking of two possible start codons in relation todetect TRs and also uses a minimum alignment score,
with smaller period TRs requiring higher numbers of
repeats to qualify. The ‘simpleRepeats’ table does not
explicitly specify the TRF input parameters - minimum
score, scoring weights, mismatch penalties, nor the
matching probability (PM) or indel probability (PI). We
determined some of these parameters empirically.
Within the table the minimum reported score was found
to be 50 and dividing this by the product of the period
by the number of repeats shows the scoring weight must
be set as 2. This infers the minimum reported STR size
is 25 bp in length.
The STaRRRT resource is a spreadsheet that outlines
the position and characteristics of 5,264 STRs present in
a 3 kb regulatory region upstream of 4,448 human NCBI
Reference Sequence gene transcripts (RefSeq, release 56
gene table; 43,284 total transcripts, 41,007 not in
haplotypic regions or unplaced contigs) [45]. STaRRRT
characterises each STR by giving, among other details:
the position of the STR in relation to the transcription
start site (TSS) of the gene (TxPos), the position of the
STR in the genome (chromosome number and the
strand on which it is situated), the period (length of the
repeated unit), the number of repeats, the consensus
sequence (or motif ), and the purity of the repeat (being
the percent match to the consensus sequence). A
complete outline of the details provided in STaRRRT is
shown in Table 1 and a sample of the STaRRRT resource
is provided as Table 2. STaRRRT is publically available
and can be accessed at http://www.newcastleinnovation
health.com.au/STaRRRT. By using the various identifiers,
genome locations or metrics, users can search, sort, filter
or merge other data with STaRRRT without the need for
extensive bioinformatics knowledge and experience. These
tasks can be handled within Excel® (Microsoft® software)
or by importing the table into a relational database.
Downstream of the TSS, STaRRRT STRs may be
located within the 5’-UTR or the coding region. We note
15,029 transcripts of the 41,007 (non-haplotype or
unplaced contig) transcripts present in RefSeq (release
56 database) have 5’-UTR regions that will go beyondve human gene. The location of the 3 kilobase (kb) regulatory region
ation of STaRRRT. As the length of the 5’-UTR can be markedly
l encompass the entire 5’-UTR for some but not all human genes. This
the regulatory region screened.
Table 1 Details provided in STaRRRT
Column name Description of field Example of entry
Chrom Chromosome number on which STR is located chr1
chromStart Start position on chromosome of the gene 28218048
chromEnd End position on chromosome of the gene 28241236
cdsStart Coding sequence start 28218673
cdsEnd Coding sequence end 28240954
Strand Strand on which the gene occurs ₋ (negative)
knownGeneId KnownGene database identifier uc001bpe.1
refSeqId1 RefSeq database identifier NM_002946
ensGeneId Ensembl database identifier ENST00000373912
sourceAcc GenBank transcript accession number NM_002946.3
hgncSymbol2 HGNC gene symbol RPA2
U133Id Affymetrix GeneChip array identifier U133A:201756_at;
U133Plus2Id Affymetrix GeneChip Plus2.0 array identifier 201756_at
Category Type of gene (coding or noncoding) coding
txPos3 Position in relation to the TSS −1910
srStart4 Start position on chromosome for the STR 28243107
srEnd End position on chromosome for the STR 28243146
Period5 Length of the repeat unit in the STR 2
numRepeats Number of copies of the repeat unit 19.5
srLength Total length of the STR 39
consensusSize Number of bases in the consensus sequence 2
perMatch6 % match of STR to consensus sequence; purity 100
perIndel Percent insertions and/or deletions in the STR 0
Score Alignment score (minimum = 50) 78
A Percent of A's (adenine) in the repeat unit 0
C Percent of C's (cytosine) in the repeat unit 0
G Percent of G's (guanine) in the repeat unit 48
T Percent of T's (thymine) in the repeat unit 51
Entropy Entropy 1
Sequence Consensus sequence of the repeat unit; motif TG
1An STR only appears in STaRRRT if the gene has a RefSeq database identifier; 2An STR only appears in STaRRRT if the gene has an HGNC Gene Symbol; 3txPos
was limited to −2000 to +1000 bp in the creation of STaRRRT; 4sr = simple repeats, as appears in the UCSC Genome Browser; 5Period was limited to 1 to 9 bp;
6perMatch was limited to ≥ 90%.
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hence, STaRRRT is not comprehensive for all STRs in
5’-UTRs. Similarly, for the 25,978 transcripts with a 5’-
UTR shorter than 1 kb, an STR (or STRs) presented in
STaRRRT may be present in the coding region. The
position of the STR within the upstream region, 5’-UTR
or coding region can be calculated by comparing the
srStart:srEnd coordinates with the chromStart:chromEnd
(transcription start and end) and cdsStart:cdsEnd (coding
sequence start and end) coordinates.
General characteristics of STaRRRT STRs relative to genic
or all STRs
Of the 41,007 (non-haplotype or unplaced contig) tran-
scripts present in RefSeq (release 56 database), 4,448gene transcripts (within 4,441 unique gene loci) were
found to contain at least one STR with purity of at least
90% in the 3 kb regulatory region analysed (Figure 1);
so, 18.8% of all genes in the human genome.
The most common STRs throughout the human gen-
ome are dinucleotides, and this is also the case for
STaRRRT STRs (Figure 2). Together, STRs with periods
of 1 and 2 comprise over half of all STRs in the STaRRRT
resource, with frequencies of 23.9% and 28.6%, respect-
ively. Compared with all (genome-wide) STRs, there are a
higher proportion of STRs with period of 1, 3, 6, 7 and 9
in the STaRRRT resource and less with periods of 4 or 8
(Figure 2). For STRs in STaRRRT, the number of STRs
generally decreases as the period increases (exceptions
include period 2, 4 and 9). This is a similar distribution to
Table 2 Sample of the resource STaRRRT
Chrom Chrom start Chrom end Strand refSeqId hgncSymbol Category tx Pos srStart srEnd Period Num repeats sr Length per Match A C G T Sequence
chr1 1102483 1102578 + NR_029639 MIR200B noncoding −586 1101897 1101928 6 5.2 31 92 19 80 0 0 CACCCC
chr1 1103242 1103332 + NR_029834 MIR200A noncoding −1345 1101897 1101928 6 5.2 31 92 19 80 0 0 CACCCC
chr1 1631377 1633247 + NR_002946 MMP23A coding −340 1631037 1631077 9 4.4 40 93 2 10 62 25 GTGTGCGGG
chr1 1950767 1962192 + NM_000815 GABRD coding −994 1949773 1949836 5 12.8 63 98 61 17 0 20 ATAAC
chr1 2487804 2495188 + NM_003820 TNFRSF14 coding 183 2487987 2488012 6 4.2 25 100 0 32 0 68 TTCTCT
chr1 2985741 3355185 + NM_022114 PRDM16 coding −121 2985620 2985645 3 8.3 25 100 0 32 68 0 GGC
chr1 3816967 3832011 + NR_024455 LOC100133612 noncoding −1887 3815080 3815118 3 12.7 38 100 68 31 0 0 AAC
chr1 6673755 6684093 + NM_153812 PHF13 coding −494 6673261 6673286 7 3.6 25 100 16 16 68 0 AGCGGGG
chr1 9352940 9429590 + NM_025106 SPSB1 coding −1705 9351235 9351260 1 25 25 100 0 0 0 100 T
chr1 9352940 9429590 + NM_025106 SPSB1 coding −157 9352783 9352812 7 4.1 29 100 0 72 27 0 CGCGCCC









































Figure 2 Comparison of STRs of different period lengths in the whole human genome, gene coding regions and STaRRRT STRs. This
histogram shows the proportion of STRs present in STaRRRT having different period (“STaRRRT”) compared to the proportions across the whole
human genome (“All STRs”), in the 2 kb upstream region (−2000, -1; “Upstream”), in the 3 kb region analysed for all STRs (with no purity restriction,
“Reg. region”), in the proximal promoter (−250, +250; “Prox. Promoter”), in exons (“Exon”), in 5’-UTRs (“5’-UTR”), and in introns (“Intron”).
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the human genome [4]. As STaRRRT STRs may overlap
the upstream region (−2000, -1 bp), proximal promoter
(−250, +250 bp), 5’-UTR and exons, the distribution of
STaRRRT STRs by period has features observed in each of
these separate distributions (Figure 2). Comparison of
STaRRRT STRs to the unfiltered set of STRs in the regu-
latory region shows the 90% purity filter of STaRRRT
increases the proportion of period 1 and 2 STRs markedly,
while STRs from all other periods are reduced. The period
1 and 2 frequencies observed in STaRRRT more closely
resemble that of 5’-UTRs and introns (Figure 2).
We note the more than 2-fold increase in the fre-
quency of STaRRRT STRs (relative to all STRs) with
period of 3. This is likely due to the encompassing of the
proximal promoter in the regulatory region and the in-
clusion of some exon regions downstream of the TSS.
Compared to all categories other than exons, the num-
ber of period 3 STRs in proximal promoters is more
than 4-fold increased. More broadly, the distribution of
STRs in proximal promoters with a multiple of 3 (being
period 3, 6 and 9) is very similar to that in exons (Figure 2).
This increase is offset by the relative decrease in frequency
of STRs with period 1 and 2.Distribution of STaRRRT STRs show distinct trends at the
TSS and in the proximal and core promoters
To assess the nature of the (high purity) STR distribu-
tion over the 3 kb regulatory region, STaRRRT period,
base composition and repeat unit length distributions
were plotted with respect to the TSS coordinate (TxPos).
Examination of the density of STRs relative to the TSS
shows a non-uniform distribution with more STaRRRT
STRs upstream of the TSS (Figure 3A) and characteris-
tics of a wave-like unevenness in density. Downstream
of the TSS, the overall density of STRs is reduced and
the local peaks and troughs in density are less distinct.
When the repeats in Figure 3A are decomposed into
subpopulations classified by repeat period, a number of
trends emerge (Figure 3B). The most striking observa-
tion is the increased density of repeats with period of 3
(trinucleotides; shown in green) in the region approxi-
mately 300 bases upstream and downstream of the TSS
and the predominance of repeats with period of 2 (dinu-
cleotides; shown in blue) in the region +300 to +1000,
downstream of the TSS. Upstream of the TSS, peaks and
troughs in repeat density are present with some regular-
ity; in particular, the density of STRs with periods of 2, 4
and 5. Using waves as an analogy, in the region −2000
















































































Position relative to TSS
Figure 3 Summary plots across the TSS. The distribution of STRs in the upstream regulatory region of the human genome shows distinct
trends around the TSS and core promoter. All lines are smoothed by LOWESS (locally weighted scatterplot smoothing) regression. (A) The density
of STaRRRT STRs across the 3 kb upstream regulatory region. This run chart shows the STR density of the 5,264 STRs from STaRRRT at each base
position in the regulatory region with a regression line also fitted to the data. (B) STaRRRT STR density decomposed into periods. (C) The number
of STR repeat units across the TSS. (D) The percentage of bases in each STR across the TSS.
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the densities of STRs with periods of 2 and 4 are in
phase before becoming anti-phased from −800 bases
until approximately −200 bases, relative to the TSS. This
change in phase coincides with an increase in the abun-
dance of STRs with period of 5.The base composition and repeat unit length of STRs
in the regulatory region also have distinct patterns. For
the most part, repeats are AT-rich; however, there is a
profound change towards GC-rich repeats, with fewer
repeat units surrounding the TSS (Figure 3C and D).
This region of change correlates strongly with the large
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(Figure 3B). These GC-rich, relatively low repeat unit
trinucleotide repeats overlap with the proximal pro-
moter, defined as 250 upstream to 250 downstream of
the TSS (−250, +250; [41] and more specifically with the
core promoter, which we define here as 60 bp upstream
to 40 bp downstream of the TSS (−60, +40). A further
decomposition of the data in Figure 3 into 3,479 CpG
island overlapping and 1,785 non-CpG island overlap-
ping regulatory regions shows the TSS proximal GC-
rich, trinucleotide repeats are situated particularly in
CpG island containing regulatory regions (Additional file
1: Figure S1). Interestingly, the smaller set of regulatory
regions without an overlapping CpG island, seem to
exclude STRs in the region just before the TSS until
approximately 100 bp downstream (Additional file 1:
Figure S2). They also exhibit a periodic and anti-phased
increase and decrease in adenine and thymine base
composition.
STaRRRT STRs are found in genes involved in metabolism,
signal transduction and the neurological system
To determine if STRs are associated with particular
biological pathways or processes, the 4,441 gene loci
within STaRRRT were analysed with gene set enrich-
ment analysis (GSEA) methods; the controlled vocabu-
lary approach implemented in the H-Invitational
Database (H-InvDB) Enrichment Analysis Tool (HEAT;
http://h-invitational.jp/hinv/ahg-db/index.jsp; [46] and
the expert curation and literature mining approach
in the Ingenuity® Pathways Analysis software (IPA;
Ingenuity® Systems, http://www.ingenuity.com). Two dis-
parate GSEA methods were used for comparison and we
gave more weight to the interpretation of findings consist-
ent to both GSEA approaches. As the degree of STR poly-
morphism in intragenic regions is also high [15], we
considered the possibility that the enrichment we ob-
served is not limited to the regulatory region, but is in-
stead representative of a broader genic enrichment
signature. For the HEAT analysis, we compared the
STaRRRT gene set enrichment findings to those of genes
with STRs in the intragenic region, so exons and introns.
In the STaRRRT set, the 5,264 STRs across the 4,441 gene
loci were mapped to 3,258 H-InvDB transcript (HIT)
identifiers (IDs) and analysed using the HEAT web tool.
For the exonic STR gene set we gathered all genes with at
least one STR in any exon regardless of purity (3,287 STRs
in 2,617 genes, mapping to 2,228 HIT IDs). As the in-
tronic region is typically much larger than the exonic or
regulatory region we found approximately a third of all
genes (13,361 genes, 24972 HIT IDs) had a least one STR
in an intron. We reduced these genes down to a size more
appropriate for gene set enrichment analysis and compar-
able to that in the STaRRRT and exonic sets. Thisreduction was performed using two approaches; a filtering
and a random subset approach. Filtering was performed
by limiting analyses to those genes with the highest quar-
tile of ≥ 90% purity STRs per kilobase of intron. This
intentional bias was based on the assumption that genes
with the uppermost high purity intronic STR densities are
more likely to have polymorphic STRs under evolutionary
selection. Filtering created a set of 17,482 STRs in 3,444
genes mapping to 2,795 HIT IDs in total. For the random
subsets, ten random samples of genes containing ≥ 90%
purity intronic STRs were subjected to HEAT analysis.
Each set had the same number of HIT IDs as the
STaRRRT STR gene set (3,258). We found some degree of
variance in the number of significant terms, particularly
for KEGG pathways (Additional file 1: Table S2). However,
the means of the number of significant terms were similar
to the high density set (Additional file 1: Table S2). Given
this variance, we only report significant terms where the
majority of samples (at least 6 from 10 samples) agreed.
These results are presented in Additional file 1: Table S3.
In comparing the two intron methods, the filtering
method reported 21 KEGG pathways as enriched (FDR
p < 0.05; Table 3), while the random subset method found
6 pathways enriched (Additional file 1: Table S3). The high
density intron set intersected to a high degree with
STaRRRT (15 from 21 pathways) and the random sample
intron set (5 from 6 pathways), so we concentrated on this
set in later analyses.
The KEGG pathways highlighted by the HEAT analysis
clustered around particular cell functions. The pathways,
grouped by KEGG Cellular Process, were associated with
nucleotide, amino acid and carbohydrate metabolism,
development, cell growth and death, signal transduction,
environmental information processing, cellular commu-
nication and motility, and the immune, nervous and
endocrine systems (Table 3). Interestingly, the KEGG
gene set enrichment analyses of STaRRRT, exonic and
the high density-enriched intronic STRs produced very
similar results; of the 21 STaRRRT enriched pathways
(FDR p < 0.05), 15 pathways were similarly enriched
(FDR p < 0.05) in the exonic and high-density intronic sets
analysed (Table 3) and all analyses identified a strong
enrichment for expression in neural tissue (Table 4), with
STaRRRT genes showing a particularly strong enrichment
(p = 4.0 × 10-10). The differences between STaRRRT
and intragenic STR genes were mostly in pathways
associated with carbohydrate metabolism, calcium and
adipocytokine signaling. The calcium signaling path-
way is the most enriched KEGG pathway for STaRRRT
STRs (p = 8.56 × 10-7) but is considerably less enriched for
exonic (p = 0.0117) and high-density intronic STR genes
(p = 0.0145). We also note, in contrast to intragenic STR
genes, STaRRRT genes are particularly expressed in the
skeletal/cardiac muscle tissue (Table 4) and are more
Table 3 KEGG pathway results from HEAT analysis grouped by pathway class
STaRRRT Exon Intron
Term ID Genes Enrich p-value Enrich p-value Enrich p-value
Metabolism
Purine metabolism 230 126 1.94 0.020 - - 2.44 0.006
Glycine, serine and threonine metabolism 260 53 - - - - 3.33 0.006
Glycosaminoglycan degradation 531 12 - - 7.14 0.006 - -
Inositol phosphate metabolism 562 54 3.04 0.002 - - 2.70 0.028
Glycan structures - biosynthesis 1 1030 40 3.24 0.005 - - - -
Glycan structures - degradation 1032 18 - - 6.00 0.006 - -
Development/Cell growth and death
Apoptosis 4210 111 2.21 0.006 2.13 0.050 2.11 0.028
Dorso-ventral axis formation 4320 80 2.03 0.048 - - 2.73 0.007
Axon guidance 4360 114 2.25 0.004 2.38 0.016 2.18 0.020
Signal transduction/Environmental information processing/Cell communication/Cell motility
Calcium signaling pathway 4020 108 3.23 8.6E-07 2.50 0.012 2.30 0.015
Phosphatidylinositol signaling system 4070 64 3.09 0.001 2.57 0.050 2.50 0.028
Wnt signaling pathway 4310 126 2.32 0.002 2.14 0.029 - -
VEGF signaling pathway 4370 155 2.33 0.001 2.09 0.020 1.89 0.032
Focal adhesion 4510 120 2.33 0.002 2.42 0.012 2.20 0.015
Adherens junction 4520 166 1.76 0.031 2.50 0.002 2.30 0.004
Tight junction 4530 101 1.95 0.038 2.68 0.007 - -
Gap junction 4540 116 2.32 0.002 2.19 0.032 2.41 0.007
Jak-STAT signaling pathway 4630 140 - - 2.73 0.002 - -
Regulation of actin cytoskeleton 4810 98 2.26 0.007 2.41 0.024 2.24 0.026
Immune system
Hematopoietic cell lineage 4640 19 - - - - 5.39 0.006
T cell receptor signaling pathway 4660 167 1.89 0.011 2.50 0.002 - -
B cell receptor signaling pathway 4662 160 1.75 0.037 2.61 0.002 - -
Leukocyte transendothelial migration 4670 99 1.88 0.051 2.73 0.006 2.06 0.043
Nervous system
Long-term potentiation 4720 125 2.34 0.002 2.17 0.028 - -
Long-term depression 4730 142 2.21 0.002 2.18 0.020 1.96 0.028
Endocrine system
Insulin signaling pathway 4910 195 1.98 0.002 2.32 0.002 2.18 0.004
Adipocytokine signaling pathway 4920 150 - - 3.01 1.3E-04 1.96 0.028
Human diseases
Type II diabetes mellitus 4930 22 3.16 0.051 - - 5.33 0.004
Epithelial cell sig. in H. pylori infection 5120 150 2.17 0.002 2.41 0.006 2.16 0.010
Colorectal cancer 5210 82 2.00 0.051 - - 2.68 0.008
Results from gene set enrichment analysis of the set of transcripts with STaRRRT STRs are shown alongside results for transcripts with STRs located in exons and
transcripts with the highest density of high purity STRs in the introns. Results shown are FDR-corrected p-values. A KEGG pathway is only presented in the table
if at least one of the STaRRRT, exon or high density intron results has an FDR-corrected p-value of less than 0.01. Columns with “-“ characters are those sets
unenriched (so p > 0.05 before FDR correction). “Genes” is the number of entities in each set and “Enrich” is the ratio of the number of transcripts observed with
STRs relative to that expected.
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http://www.biomedcentral.com/1471-2164/14/795abundantly located in the endoplasmic reticulum and
plasma membrane of the cell (GO Cellular Components,
Additional file 1: Table S1). Also, STaRRRT STR genes are
associated with a larger number and hence wider range of
biological processes and molecular functions than intragenicSTR genes (GO Biological Process, GO Molecular Func-
tion; Additional file 1: Table S1).
The IPA Top Canonical Pathways and Top Bio Func-
tions analyses (Table 5) were in strong agreement with
the HEAT results. Again, most pathways were associated
Table 4 Tissue-specific expression results from HEAT analysis
STaRRRT Exon Intron
Tissue Genes Enrich p-value Enrich p-value Enrich p-value
Kidney/bladder 139 - - 2.08 0.014 2.21 0.003
Muscle/heart 168 2.01 0.001 - - - -
Neural 393 2.23 4.0E-10 1.80 0.003 2.01 8.1E-06
Placenta/testis/ovary 198 1.88 0.001 1.93 0.014 - -
A description of the columns is given in Table 3.
Bolton et al. BMC Genomics 2013, 14:795 Page 10 of 16
http://www.biomedcentral.com/1471-2164/14/795with signal transduction, metabolism, cell growth and
death and immune, endocrine and nervous system func-
tion. Interestingly, in the IPA Diseases and Disorders
analysis, several have a neurological basis; with neuro-
logical disease (including mood disorders (p = 1.81 × 10-4),
Huntington’s disease (p = 0.00571), neuromuscular disease
(p = 0.00878) and major depression (p = 0.0173)) and psy-
chological disorders (including schizophrenia (p = 0.00289),
bipolar disorder (p = 4.06 × 10-4) and depressive disorder
(p = 0.00286)) listed as the top two (Table 5).
Collectively, the GSEA results show that genes with
STRs in the regulatory region or exons, or those genes
with high intronic STR density, have enrichments for
largely the same classes of gene pathways. These path-
ways are primarily associated with metabolism, signal
transduction, environmental information processing,
development, cell growth, death, motility and communi-
cation and immune, nervous and endocrine system func-
tion. There are some differences between the STaRRRT,
exonic and high-density intronic gene sets in KEGG
pathways. Broadly, STaRRRT genes have more numerous
enrichments and are particularly enriched for calcium
signaling.Discussion
By genome-wide analysis, this study has identified that
18.8% of all human genes contain at least one highly
pure STR in their upstream regulatory region. This is
consistent with the previous suggestion that TRs of all
period lengths are present within promoter regions of 10
to 20% of human genes [4]. The upstream promoter
region appears to consist of predominantly short (mostly
with repeat period of 1 and 2), AT-rich sequences, which
is concordant with the findings of Vinces et al. [5] in the
yeast genome and Sawaya et al. [2] in human promoters.
We demonstrate that in humans, the proximal promoter
(−250, +250) and in particular the region overlapping
the typical core promoter region (−60, +40) have GC-
rich STRs. As approximately 72% of human promoters
have high GC-content [47,48] with CpG island density
reaching a maximum near the TSS [47], we reason this
increase in STR GC-content reflects the underlying GC-
rich promoter sequence.Consistent with a previous genome-wide survey of all
STRs [1], period 2 STRs (dinucleotides) are the most
abundant STRs in the regulatory region across human
genes. Likewise, the distribution of STaRRRT STRs
across repeat periods is very similar to that reported by
Gemayel et al. (2010) for the distribution of all TRs in
noncoding regions across the human genome [4].
However, similar to coding regions, we find a striking
enrichment of trinucleotide repeats (period 3 STRs) in
the proximal promoter region, both upstream and
downstream of the TSS (Figure 3B). The similarity of
this enrichment signature in regulatory regions to that
observed in coding regions [3] is a significant and novel
finding, and adds weight to the likely functional signifi-
cance of these results.
STRs in coding regions almost exclusively have a
repeat period which is a multiple of 3 bases [4]; this is
thought to be due to the nature of triplet codons and
selection against frameshift mutations [49]. While the
region upstream of the TSS is not transcribed, the
abundance of trinucleotide repeats suggests a selection
pressure of similar magnitude to that observed in coding
regions [3,50]. Possible explanations include alternative
translation start sites or other functional constraints,
possibly related to chromatin structure, nucleosome
positioning and/or transcription factor activity. We
note that high abundance TSS proximal GC-rich re-
peats and trinucleoide repeats are only associated with
regulatory regions overlapping CpG islands. Interestingly,
the smaller non-CpG island overlapping group is com-
posed of mostly dinucleotides repeats and in the region
approximately −500 to 500 bp around the TSS the repeats
have a regular wavelike increase and decrease in adenine
and thymine abundance. We speculate this pattern may
be associated with nucleosome positioning.
Broadly, we suggest that the distribution of STRs
around the promoter has functional significance, as also
proposed recently by Sawaya et al. [2] following their
discovery of a high density of STRs at the TSS and by
Kozlowski et al. [3] who found non-random distribution
of trinucleotide repeats in the exome. Altered TR length
in or near core promoters can change local nucleosome
positioning, is likely to hinder transcription factor bind-
ing and therefore affect rates of transcription and hence
Table 5 IPA results
Top Bio Functions Molecules (n) p-value
Diseases and disorders
Neurological disease 443 1.27E-04 - 4.94E-02
Psychological disorders 236 1.81E-04 - 4.94E-02
Developmental disorder 132 9.19E-04 - 4.24E-02
Antimicrobial response 29 1.38E-03 - 2.00E-02
Infectious disease 418 2.25E-03 - 4.17E-02
Molecular and cellular functions
Cellular movement 325 3.39E-04 - 4.81E-02
Cell death and survival 501 6.18E-04 - 4.83E-02
Cell-to-cell signaling and interaction 119 1.07E-03 - 4.81E-02
Cellular development 290 1.17E-03 - 4.37E-02
Cellular growth and proliferation 192 1.47E-03 - 4.81E-02
Physiological system development and functions
Cardiovascular system development and function 167 7.56E-06 - 4.70E-02
Organismal development 146 3.20E-05 - 4.37E-02
Humoral immune response 12 1.38E-03 - 4.81E-02
Reproductive system development and function 31 1.47E-03 - 4.17E-02
Hematological system development and function 107 1.74E-03 - 4.81E-02
Top 20 canonical pathways Ratio p-value
NGF signaling 34/111 (0.306) 3.16E-03
Pyridoxal 5'-phosphate salvage pathway 22/62 (0.355) 4.22E-03
Reelin signaling in neurons 26/82 (0.317) 6.29E-03
Neuropathic pain signaling in dorsal horn neurons 31/102 (0.304) 6.92E-03
GNRH signaling 38/135 (0.281) 7.00E-03
Cellular effects of sildenafil (Viagra) 37/127 (0.291) 9.28E-03
Calcium signaling 48/189 (0.254) 1.01E-02
Factors promoting cardiogenesis in vertebrates 27/91 (0.297) 1.27E-02
Synaptic long-term depression 39/142 (0.275) 1.51E-02
B cell receptor signaling 43/162 (0.265) 1.95E-02
FGF signaling 26/88 (0.295) 2.01E-02
mTOR signaling 49/189 (0.259) 2.06E-02
Gɑq signaling 40/157 (0.255) 2.33E-02
Dopamine-DARPP32 feedback in cAMP signaling 43/161 (0.267) 2.40E-02
D-myo-inositol (1,4,5)-triphosphate biosynthesis 10/26 (0.385) 2.66E-02
PPARɑ/RXRɑ activation 44/173 (0.254) 2.86E-02
NF-κB activation by viruses 22/79 (0.278) 3.18E-02
Xenobiotic metabolism signaling 66/268 (0.246) 3.20E-02
Antioxidant action of vitamin C 27/98 (0.276) 3.43E-02
Maturity onset diabetes of young (MODY) signaling 8/22 (0.364) 3.64E-02
Results from comparison of the set of transcripts containing STaRRRT STRs with the reference set Ingenuity Knowledge Base are shown. For “Top Bio Functions”,
the number of molecules (n) relates to genes containing STaRRRT STRs in each enriched functional group. For “Top Canonical Pathways”, the number of
STR-containing genes, relative to the total number of genes for each canonical pathway, is shown as a fraction and as a ratio (in brackets). Results shown are
limited to those with a p-value less than 0.05 for the “Top Bio Functions” and the 20 most significant results with a p-value less than 0.05 for the “Top
Canonical Pathways”.
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http://www.biomedcentral.com/1471-2164/14/795gene expression [51,52]. It has been shown that changes
as small as 2 bp in nucleosome positioning can alter
promoter activity [52]. Moreover, it has been shown in
yeast that nucleosome position is negatively correlatedwith the positioning of TRs [5]. Hence, our findings of
profound changes in STR period, repeat unit number
and base composition around the TSS of human genes
is interesting given the findings in yeast and indicate that
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http://www.biomedcentral.com/1471-2164/14/795similar mechanisms of regulating gene expression may
be at play in the human genome [52]. In this regard, a
recent study has shown that a polymorphic GA-repeat
in the human SOX5 gene promoter can affect gene
expression, with the longer allele resulting in a 2.7-fold
increase in activity [53]. The authors report this as first
evidence of a functional STR in a human gene core
promoter [53].
Controlled vocabulary gene set enrichment analysis of
gene transcripts with STaRRRT STRs in the regulatory
region found a number of significantly enriched KEGG
pathways, GO terms and tissues enriched for expression
of these genes. These findings have broad overlap with
gene set enrichment of gene transcripts having STRs in
the exons and those gene transcripts with a high density
of STRs in the intronic regions. Regulatory region, exon
and intron analyses all show enrichment for expression
in neural tissue. Enrichment of neurological genes and
pathways in the STaRRRT analysis is consistent with the
known role of TRs in neurodegenerative and neurodeve-
lopmental disorders [37]. Several neurological diseases
known to be caused by variable TRs also appeared in the
STaRRRT IPA results, namely Huntington’s disease and
neuromuscular disease, as well as major depression which
has a known association with a variable TR [54]. STaRRRT
can be used to analyse the role STRs may play in the
development of various diseases, such as neurological
disorders and cancer in which they have already been
implicated. This could potentially lead to the identification
of targets for diagnosing and treating diseases.
While the STaRRRT, exonic and intronic gene set
enrichment results show a very high degree of overlap,
we also note some differences between the enrichment
signatures. The calcium signaling pathway was the most
enriched KEGG pathway for STaRRRT STRs but is only
mildly enriched in the exonic and intronic gene sets. In
particular, STRs were significantly enriched in the regu-
latory region of genes involved in the calcium signaling
pathway (KEGG), calcium ion binding (GO Molecular
Function) and ion transport and activity (GO Biological
Process and Function, respectively, which includes cal-
cium transporters). Intracellular calcium signaling regu-
lates a plethora of cellular processes including apoptosis,
gene transcription, proliferation, cell cycle progression
and differentiation [55]. Disruption is associated with a
number of diseases such as Alzheimer’s disease, diabetes,
skin disorders, cardiac disease and cancer [56]. Previous
studies have shown STRs can impact calcium signaling
with the identification of an expansion in the CAG
repeat in exon 1 of isoforms ‘a’ and ‘c’ of KCNN3 and
the 5’-UTR of isoform ‘b’ of KCNN3, which encodes a
calcium activated potassium channel [45,57]. The expan-
ded variant of KCNN3 has been reported to reduce chan-
nel conductance and is associated with better cognitiveperformance of individuals with schizophrenia [57]. An
enriched presence of STRs in the regulatory region of the
calcium signaling machinery has not previously been re-
ported and may have significant consequences for protein
expression and function and consequently disease. Fur-
ther, the second most enriched KEGG pathway, vascular
endothelial growth factor (VEGF) signaling, is associated
with vasculogenesis and angiogenesis. We note that only
STaRRRT genes were enriched for expression in skeletal
and cardiac muscle and in the IPA analysis, cardiovascular
system development and function was listed as the most
enriched physiological system (Table 5).
The GSEA findings are consistent with mechanisms of
human evolution. Due to their inherent instability, the
presence of variable STRs in regulatory regions may act
as a flexible switch to allow ready adaptation through
positive selection with implications for human evolution
and disease. The enrichment of neural processes and
pathways is concordant with the involvement of TRs in
the evolution of cognition and behaviour [58], support-
ing the idea of Legendre et al. (2007) that repeats may
play a role in the swift evolution of the primate brain.
The over-representation of STaRRRT genes involved in
transcriptional regulation (Additional file 1: Table S1)
further supports a role for STRs in evolutionary mecha-
nisms, given the suggested role for polymorphic TRs in
modifying transcription and leading to rapid evolution-
ary changes [59,60]. Haygood et al. (2007) surveyed base
substitution rates in human genomic regions upstream
of the TSS and compared these with neighbouring
intronic sequence and also substitution rates in chimpan-
zees. High rates of base substitution (compared to intronic
rates) in human, but not chimpanzee promoters, were
observed in genes involved in neuronal function, develop-
ment, glycolysis and carbohydrate metabolism, protein
folding, vision, oncogenesis and anion transport [61]. This
list of enriched biological processes shows much resem-
blance with the current study. Therefore, we hypothesise
that the set of enriched STaRRRT STRs is reflective of
general positive selection in human promoter regions
since our divergence from chimpanzees.
The importance of STRs has been recognised due to
their abundance in the human genome, high mutation
rates, and relevance to disease phenotypes and evolu-
tionary processes. As technologies improve and analysis
of repetitive sequences becomes simpler and more cost
effective, resources such as STaRRRT will become more
valuable and commonly utilised in biological studies.
Further applications for the use of STRs include the
study of how environmental factors (such as radiation or
toxic compounds) affect genomic mutation rate [7],
which would rely upon a thorough understanding of the
baseline mutation rates and other characteristics of STRs
in the human genome.
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STaRRRT acts as a starting point for researchers inter-
ested in looking at the role of STRs in promoter regions
throughout the human genome. It is publically available
and can be accessed at http://www.newcastleinnovation
health.com.au/STaRRRT. This resource is suitable for
researchers with limited bioinformatics experience who
are interested in specific STRs, genes or phenotypes.
Multiple database identifiers are available in STaRRRT
including Affymetrix array probeset identifiers which
allow legacy gene expression data to be easily mapped to
this table.
This paper presents the findings from investigations of
the distribution and abundance of STRs in the 5’ regula-
tory region of human genes. We have identified a unique
signature of STR enrichment in this regulatory region
which is most pronounced within neural genes, and cal-
cium signaling and neurological pathways. This func-
tional signature of STR enrichment in the regulatory
regions of genes is similar to that previously identified in
coding regions, suggesting that regulatory region STRs
are subject to similar evolutionary pressures and may
have an important role in gene expression. Hence, this
study has identified STRs likely to be involved in the
expression of genes associated with particular disease
phenotypes and recent evolution of the human genome.
Methods
Resource construction
The STaRRRT resource was constructed in a series of
nested table joins in MySQL database (SQL commands
provided in Additional file 2). The tables, in hg19 build
coordinates, were downloaded from the UCSC Genome
Browser (http://genome.ucsc.edu/index.html). The geno-
me-wide table of tandem repeats identified by the Tandem
Repeat Finder program [39] was reduced to the set of
highly pure STRs by filtering for TRs with a length less
than or equal to 9 bp and repeat purity of at least 90%. The
analysis was then further restricted to those STRs proximal
to the transcription start site (TSS) of genic loci with a
RefSeq identifier. In instances where genic loci had more
than one RefSeq transcript, the canonical transcript as
defined by UCSC was used. For each canonical TSS, we
entrained analyses to a span around the TSS rather than
include all the 5’-UTR. This is due to approximately 11%
of RefGene curated transcripts, in particular transcribed
pseudogenes and noncoding genes, not having a defined
5’-UTR. The 5’-UTR is also highly variable in size; while
most genes have a short 5’-UTR (median length of 292 bp
and mean of 9885 bp), some genes have particularly long
5’-UTRs, for example, the transcript (NM_002839) of
PTPRD has a 5’-UTR length of around 1.88 Mb.
For each STR in STaRRRT, containment within the
regulatory region was defined as having start and endsites contained within the region 2 kb upstream of a TSS
to 1 kb downstream (Figure 1). These STRs were given a
relative coordinate with respect to the TSS (TxPos),
defined as the number of nucleotides upstream or down-
stream from the STR start coordinate to the TSS. We
also joined other identifiers (IDs) to this table such as
KnownGene and Ensemble database IDs, NCBI RefSeq
and GenBank accession numbers, HGNC gene symbols
and Affymetrix array probeset IDs so legacy gene ex-
pression data can easily be mapped to this table. The
final Short Tandem Repeats in Regulatory Regions table
(STaRRRT) is a list of all the highly pure STRs present
in the 3 kb regulatory region at the 5’-end of all human
genes. This table was exported from MySQL into R
(v2.15.0) and converted into an Excel spreadsheet. The
SQL code used to construct the table is provided in
Additional file 2.
Analysis of density of STRs and base composition in
relation to the TSS
Using the functionality of the ‘GenomicRanges’ R library,
we calculated from all STRs in the genome the subsets
that are located within exons, introns or 5’-UTRs and
those STRs located upstream (−2,000 to −1 bp), in the
proximal promoter (−250 to +250 bp) or regulatory
region (−2,000 to +1,000 bp), relative to the TSS. An
STR qualified as being located within an entity if some
portion of it overlapped.
To calculate STR density, for each STR the start and
end coordinates (relative to the TSS) were used to
generate a sum of STRs at each base position across the
regulatory region. The sums were used to form a density
per base and these densities smoothed using LOWESS
local regression. Similarly, the base composition and
repeat unit lengths were calculated for each base posi-
tion across the regulatory region and were smoothed
using local regression. For further detail consult the R
scripts or the HTML-based report in Additional file 2.
Gene set enrichment analysis
Two gene set enrichment analysis approaches, the H-
InvDB Enrichment Analysis Tool (HEAT; http://h-
invitational.jp/HEAT/search.do) and Ingenuity Pathway
Analysis (IPA; Ingenuity® Systems; http://www.ingenuity.
com) were used to functionally characterise the list of
genes from STaRRRT. For the HEAT analysis, Known-
Gene IDs within STaRRRT were mapped to HIT IDs
(identifiers of an RNA transcript from the H-InvDB data-
base), using the UCSC ‘knownToHInv’ table. Additional
STR tables were prepared by filtering all STRs in the gen-
ome to those within exons and introns. Given the high
number of transcripts with at least one STR in an intron
we needed to reduce this set for GSEA. We created two
sets; transcripts with a high-density of STRs in introns
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trons. For the high-density set, filtering was introduced by
limiting to those STRs with a purity ≥ 90% and to those
genes with the highest quartile of STR density within the
intronic region (one high purity STR per 7.32 kb intron).
The density was calculated by summing the total intron
width per gene and dividing this by the total number of
STRs present in the introns of that gene. For the random
sampling approach, ten HIT ID sets, each the same size as
the STaRRRT set (3,258) were sampled from the 9,299
HIT IDs in the complete high purity intron set.
All sets were subjected to HEAT analysis and the
returned tables were imported into R, processed and the
p-values multiplicity corrected using a false discovery rate
(FDR) correction from the Bioconductor ‘multtest’ library
based upon the number of tests performed. An R script in
Additional file 2 discloses all the processing steps.
For the IPA analysis, the list of 4,448 RefSeq gene tran-
script IDs was uploaded and, when compared against the
reference set Ingenuity Knowledge Base (Genes Only), a
list of 4,377 “analysis-ready molecules across observations”
was created. A Core Analysis was run and the output in-
cluded enrichment in the categories “Top Bio Functions”
(including Diseases and Disorders, Molecular and Cellular
Functions, and Physiological System Development and
Function) and “Top Canonical Pathways”.
Additional files
Additional file 1: Supplementary materials (Figures S1-S2;
Tables S1-S3).
Additional file 2: Supplementary methods. (SQL code; R scripts;
R/Markdown HTML-based report).
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